Robert Ross Carter insider trades: Oncology Institute (TOI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | TOI | ↓ Sell | 247 | $3.56 | $879 | Direct | Jan 5, 2026 (3d) |
| Mar 26, 2025 | TOI | ↑ Buy | 9,056 | $1.04 | $9K | Direct | Mar 28, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TOI insiders
Open-market trades in the last 12 months
About Robert Ross Carter's insider trades
Robert Ross Carter is Chief Financial Officer at Oncology Institute (TOI). Since Mar 26, 2025, Robert has reported 1 open-market purchase worth $9K and 1 sale worth $879 on SEC Form 4. In the last 12 months: 1 sale ($879).
Their filings also include other transactions (4 filings), shares returned to the company (4 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TOI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.